HIV-1 replication increases HIV-specific CD4+ T cell frequencies but limits proliferative capacity in chronically infected children. 2003

Zachary A Scott, and Coreen M Beaumier, and Mark Sharkey, and Mario Stevenson, and Katherine Luzuriaga
Graduate Program in Immunology/Virology and Department of Pediatrics, University of Massachusetts Medical School, Worcester, MA 01605, USA.

This study investigated the relationship between HIV-1 replication and virus (HIV-1; CMV)-specific CD4(+) T cell frequency and function in HIV-1-infected children. HIV-1 gag p55-specific CD4(+) T cell IFN-gamma responses were detected in the majority of children studied. p55-specific responses were detected less commonly and at lower frequencies in children with <50 copies/ml plasma HIV-1 RNA than in children with active HIV-1 replication. In children with <50 copies/ml plasma HIV-1, p55-specific responses were detected only in children with evidence of ongoing HIV-1 replication, indicating a direct relationship between HIV-1 replication and HIV-specific CD4(+) T cell frequencies. In contrast, p55-specific proliferative responses were detected more frequently in children with <50 copies/ml plasma HIV-1. CMV-specific CD4(+) responses were more commonly detected and at higher frequencies in CMV-coinfected children with suppressed HIV-1 replication. The lack of HIV-specific CD4(+) proliferative responses, along with the preservation of CMV-specific CD4(+) responses in children with controlled HIV-1 replication, suggests that viral replication may have deleterious effects on HIV-1 and other virus-specific CD4(+) responses. Vaccination to stimulate HIV-specific CD4(+) T cell responses in these children may synergize with antiretroviral therapy to improve the long-term control of viral replication, and may perhaps allow the eventual discontinuation of antiretroviral therapy.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008231 Lymphopenia Reduction in the number of lymphocytes. Lymphocytopenia,Lymphocytopenias,Lymphopenias
D010750 Phosphoproteins Phosphoprotein
D011498 Protein Precursors Precursors, Protein
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic

Related Publications

Zachary A Scott, and Coreen M Beaumier, and Mark Sharkey, and Mario Stevenson, and Katherine Luzuriaga
January 2006, Journal of clinical immunology,
Zachary A Scott, and Coreen M Beaumier, and Mark Sharkey, and Mario Stevenson, and Katherine Luzuriaga
March 1999, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
Zachary A Scott, and Coreen M Beaumier, and Mark Sharkey, and Mario Stevenson, and Katherine Luzuriaga
March 2021, The Journal of clinical investigation,
Zachary A Scott, and Coreen M Beaumier, and Mark Sharkey, and Mario Stevenson, and Katherine Luzuriaga
August 1993, Journal of acquired immune deficiency syndromes,
Zachary A Scott, and Coreen M Beaumier, and Mark Sharkey, and Mario Stevenson, and Katherine Luzuriaga
September 2003, AIDS research and human retroviruses,
Zachary A Scott, and Coreen M Beaumier, and Mark Sharkey, and Mario Stevenson, and Katherine Luzuriaga
November 2006, Zhonghua yi xue za zhi,
Zachary A Scott, and Coreen M Beaumier, and Mark Sharkey, and Mario Stevenson, and Katherine Luzuriaga
May 1995, Human gene therapy,
Zachary A Scott, and Coreen M Beaumier, and Mark Sharkey, and Mario Stevenson, and Katherine Luzuriaga
January 2012, The open virology journal,
Zachary A Scott, and Coreen M Beaumier, and Mark Sharkey, and Mario Stevenson, and Katherine Luzuriaga
January 2012, PloS one,
Zachary A Scott, and Coreen M Beaumier, and Mark Sharkey, and Mario Stevenson, and Katherine Luzuriaga
November 2005, Clinical and experimental immunology,
Copied contents to your clipboard!